Pharmacokinetics and dosimetry of the antiandrogen vinclozolin after oral administration in the rat

Toxicological Sciences

Volumn 106, Issue 1, 2008, Pages 55-63

  Sierra Santoyo, Adolfo ^a   Castañeda Hernández, Gilberto ^a   Harrison, Randy A ^a   Barton, Hugh A ^b   Hughes, Michael F ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Antiandrogenic; Biomarkers; Dicarboximides; Vinclozolin

Indexed keywords

2 [[(3,5 DICHLOROPHENYL)CARBAMOYL]OXY] 2 METHYL 3 BUTENOIC ACID; 3',5' DICHLORO 2 HYDROXY 2 METHYLBUT 3 ENANILIDE; 3',5' DICHLORO 2,3,4 TRIHYDROXY 2 METHYLBUTYLANILIDE; CHEMICAL COMPOUND; CORN OIL; UNCLASSIFIED DRUG; VINCLOZOLIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; COMPARTMENT MODEL; CONTROLLED STUDY; DOSIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY PARENCHYMA; LIVER LEVEL; LONG EVANS RAT; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; TISSUE DISTRIBUTION; TISSUE LEVEL; TOXICOKINETICS;

ADMINISTRATION, ORAL; ANDROGEN ANTAGONISTS; ANIMALS; BIOLOGICAL MARKERS; BIOTRANSFORMATION; MALE; MODELS, BIOLOGICAL; OXAZOLES; RATS; RATS, LONG-EVANS; TISSUE DISTRIBUTION;

RATTUS; ZEA MAYS;

EID: 54349096582     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn167     Document Type: Article

References (32)

1. Baker, L. M. (1998). Introduction. In Standard Methods for the Examination of Water and Wastewater, 19th edn. (L. S. Clesceri, A. E. Greenberg, and A. D. Eaton, Eds.), Port City Press, Washington, DC.
2. Bayley, M., Junge, M., and Baatrup, E. (2002). Exposure of juvenile guppies to three antiandrogens causes demasculinization and a reduced sperm count in adult males. Aquat. Toxicol. 56, 227-239.
3. Bisenius, E. S., Veeramacheneni, D. N., Sammonds, G. E., and Tobet, S. (2006). Sex differences and the development of the rabbit brain: Effects of vinclozolin. Biol. Reprod. 75, 469-476.
4. Bursztyka, J., Debrauwer, L., Perdu, E., Houanin, I., Jaeg, J.-P., and Cravedi, J.-P. (2008). Biotransformation of vinclozolin in rat precision-cut liver slices: Comparison with in vivo metabolic pattern. J. Agric. Food Chem. 56, 4832-4839.
5. Crews, D., Gore, A. C., Hsu, T. S., Dangleben, N. L., Spinetta, M., Schallert, T., Anway, M. D., and Skinner, M. K. (2007). Transgenerational epigenetic imprints on mate preference. Proc. Natl. Acad. Sci. U. S. A. 104, 5942-5946.
6. Dean, G. M., Kirkpatrick, D., Riseborough, J., Biggs, S. R., Hawkins, D. R., Kohl, W., and Hubert, R. (1988). Identification of metabolites of vinclozolin in hen liver. Proc. Brit. Crop Prot. Conf. 2, 693-698.
7. Euling, S. Y., Gennings, C., Wilson, E. M., Kempainned, J. A., Kelce, W. R., and Kimmel, C. A. (2002). Response-surface modeling of the effects of 5alpha-dihydrotestosterone and androgen receptor levels on the response to the ahdrogen receptor antagonist vinclozolin. Toxicol. Sci. 69, 332-343.
8. Gibaldi, M., and Perrier, D. (1975). In Pharmacokinetics (J. Swarbrick, Ed.), Marcel Dekker, Inc, New York, NY.
9. Gray, L. E., Jr., Ostby, J. S., and Ketce, W. R. (1994). Developmental effects of environmental antiandrogens: The fungicide vinclozolin alters sex differentiation of the male rat. Toxicol. Appl. Pharmacol. 129, 46-52.
10. Kelce, W. R., Lambright, C. R., Gray, L. E., and Roberts, K. P. (1997). Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: In vivo confirmation of an androgen-receptor-mediated mechanism. Toxicol. Appl. Pharmacol. 142, 192-200.
11. Kelce, W. R., Monosson, E., Gamcsik, M. P., Laws, S. C., and Gray, L. E., Jr. (1994). Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol. Appl. Pharmacol. 126, 276-285.
12. Makynen, E. A., Kahl, M. D., Jensen, K. M., Tietge, J. E., Wells, K. L., Van der Kraak, G., and Ankley, G. T. (2000). Effects of the mammalian antiandrogen vinclozolin on development and reproduction of the fathead minnow (Pimephales promelas). Aquat. Toxicol. 48, 461-475.
13. Molina-Molina, J. M., Hillenweck, A., Jouanin, I., Zalko, D., Cravedi, J. P., Fernández, M. F., Pillon, A., Nicolas, J. C., Olea, N., and Balaguer, P. (2006). Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol. Appl. Pharmacol. 216, 44-54.
14. Monosson, E., Kelce, W. R., Lambright, C., Ostby, J., and Gray, L. E., Jr. (1999). Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues and alters receptor function in the male rat. Toxicol. Ind. Health 15, 65-79.
15. Mu, X., Liu, K., Kleymenova, E., Sar, M., Young, S. S., and Gaido, K. W. (2006). Gene expression profiling of androgen receptor antagonists in the rat fetal testis reveals few common gene targets. J. Biochem. Mol. Toxicol. 20, 7-17.
16. Nagaosa, K., Kishimoto, A., Kizu, R., Nakagawa, A., Shiratsuchi, A., and Nakanishi, Y. (2007). Perturbation of spermatogenesis by androgen antagonists directly injected into seminiferous tubules of live mice. Reproduction 133, 21-27.
17. Orlando, E. F., and Guillette, L. J., Jr. (2007). Sexual dimorphic responses in wildlife exposed to endocrine disrupting chemicals. Environ. Res. 104, 163-173.
18. Pothuluri, J. V., Freeman, J. P., Heinze, T. M., Beer, R. D., and Cerniglia, C. E. (2000). Biotransformation of vinclozolin by the fungus Cunninghamella elegans. J. Agric. Food Chem. 48, 6138-6148.
19. Rider, C. V., Furr, J., Wilson, V. S., and Gray, L. E., Jr. (2008). A mixture of seven antiandrogens induces reproductive malformations in rats. Int. J. Androl. 31, 249-262.
20. Ronis, M. J. J., Ingelman-Sundberg, M., and Badger, T. M. (1994). Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochem. Pharmacol. 48, 1953-1965.
21. Schick, B., Moza, P. N., Hustert, K., and Kettrup, A. (1999). Photochemistry of vinclozolin in water and methanol-water solution. Pestic. Sci. 55, 1116-1122.
22. Sierra-Santoyo, A., Barton, H. A., and Hughes, M. F. (2004). Liquid chromatography determination of the anti-androgen vinclozolin and its metabolites in rat serum. J. Chromatogr. B 809, 105-110.
23. Sierra-Santoyo, A., Harrison, R., Edwards, B. C., Barton, H. A., and Hughes, M. F. (2006). Metabolism and dosimetry of vinclozolin in rat. Toxicol. Sci. 90(Suppl.), 121 (Abstract).
24. Szeto, S. Y., Burlinson, N. E., Rahe, J. E., and Oloffs, P. C. (1989). Kinetics of hydrolysis of the dicarboximide fungicide vinclozolin. J. Agric. Food Chem. 37, 523-529.
25. Tanabe, S. (2002). Contamination and toxic effects of persistent endocrine disrupters in marine mammals and birds. Mar. Pollut. Bull. 45, 69-77.
26. Uzumcu, M., Suzuki, H., and Skinner, M. K. (2004). Effect of the antiandrogenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod. Toxicol. 18, 765-774.
27. Vanni, A., Gamberini, R., Calabria, A., and Pellegrino, V. (2000). Determination of presence of fungicides by their common metabolite, 3,5-DCA, in compost. Chemosphere 41, 453-458.
28. Wittke, K., Hajimiragha, H., Dunemann, L., and Bejerow, J. (2001). Determination of dichloroanilines in human urine by GC-MS, GC-MS-MS and GC-ECD. J. Chromatogr. B 755, 215-228.
29. Wolf, C. J., LeBlanc, G. A., Ostby, J. S., and Gray, L. E., Jr. (2000). Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol. Sci. 55, 152-161.
30. Wong, C., Kelce, W. R., Sar, M., and Wilson, E. M. (1995). Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270 19998-20003.
31. Yang, M., Park, M. S., and Lee, H. S. (2006). Endocrine disrupting chemicals: Human exposure and health risks. J. Environ. Sci. Health Part C 24, 183-224.
32. Zober, A., Hoffman, G., Ott, M. G., Will, W., Germann, C., and van Ravenzwaay, B. (1995). Study of morbidity of personnel with potential exposure to vinclozolin. Occup. Environ. Med. 52, 233-241.